about
The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.A framework for in vitro systems toxicology assessment of e-liquids.Biological impact of cigarette smoke compared to an aerosol produced from a prototypic modified risk tobacco product on normal human bronchial epithelial cells.Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette.High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC).Systems biology approach for evaluating the biological impact of environmental toxicants in vitro.The biological effects of long-term exposure of human bronchial epithelial cells to total particulate matter from a candidate modified-risk tobacco product.In vitro systems toxicology-based assessment of the potential modified risk tobacco product CHTP 1.2 for vascular inflammation- and cytotoxicity-associated mechanisms promoting adhesion of monocytic cells to human coronary arterial endothelial cellsHow complex should an in vitro model be? Evaluation of complex 3D alveolar model with transcriptomic data and computational biological network modelsGladiaTOX: GLobal Assessment of Dose-IndicAtor in TOXicologyIn Vitro High-Content Imaging-Based Phenotypic Analysis of Bronchial 3D Organotypic Air-Liquid Interface CulturesApplication of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e-cigarette device with MESH™ technologyA lung/liver-on-a-chip platform for acute and chronic toxicity studies
P50
Q37114836-E9C5FEC2-AF2A-45D1-8446-9C9A08050918Q37642797-796BB69E-9598-4AC3-B97A-C81437F7644BQ38843471-FE987328-C45D-4199-BB6A-D231F483D60DQ39588027-5F700E4B-AA5E-4954-A8D4-E101B0B39A1FQ39629519-881E779F-0070-417A-83A0-CB3C1CFC3284Q39773325-092DB14A-8BB3-4D65-811E-F641E04A80BFQ39919119-7AF183AC-8C6C-485B-877B-C30670AC2966Q40228525-E35155B6-D25B-4772-9C5E-4BF1FECBAE60Q41894692-2BDCDD01-9717-43F3-A72B-6C123E534891Q42228988-010A3472-832B-433C-ACFB-F92A22CA752FQ46945920-C5718EE4-A1B5-4407-9CEC-D4FCA44E2E26Q51741915-95755341-C8D0-4205-A6D3-9832DC229217Q90347757-20C38EFA-6D58-4651-B766-9EF496985544Q91502873-ABC254AD-3FD5-4B98-8934-C6D644080DEBQ92377918-38DF592C-A133-4EAA-95A9-AB599B9FAAA1Q92868877-8224A611-6D61-4719-B68A-7C774D72418BQ93172933-5D125295-1B3D-451F-9183-ABB521C801D5Q93257747-BE36F7AA-6C75-457B-89B1-8677EE88B15E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Diego Marescotti
@en
Diego Marescotti
@nl
type
label
Diego Marescotti
@en
Diego Marescotti
@nl
prefLabel
Diego Marescotti
@en
Diego Marescotti
@nl
P31
P496
0000-0003-1007-8074